###begin article-title 0
###xml 41 46 <span type="species:ncbi:9606">Human</span>
Interaction between polymorphisms of the Human Leukocyte Antigen and HPV-16 Variants on the risk of invasive cervical cancer
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 45 65 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 67 70 <span type="species:ncbi:10566">HPV</span>
###xml 162 165 <span type="species:ncbi:10566">HPV</span>
###xml 375 378 <span type="species:ncbi:10566">HPV</span>
Persistent infection with oncogenic types of human papillomavirus (HPV) is the major risk factor for invasive cervical cancer (ICC), and non-European variants of HPV-16 are associated with an increased risk of persistence and ICC. HLA class II polymorphisms are also associated with genetic susceptibility to ICC. Our aim is to verify if these associations are influenced by HPV-16 variability.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQA1</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 17 20 <span type="species:ncbi:10566">HPV</span>
We characterized HPV-16 variants by PCR in 107 ICC cases, which were typed for HLA-DQA1, DRB1 and DQB1 genes and compared to 257 controls. We measured the magnitude of associations by logistic regression analysis.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 123 131 123 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*05 </italic>
###xml 367 381 367 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA DRB1*1302 </italic>
###xml 542 550 542 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15 </italic>
###xml 725 733 725 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*04 </italic>
###xml 827 830 827 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E6 </italic>
###xml 898 906 898 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*05 </italic>
###xml 211 214 <span type="species:ncbi:10566">HPV</span>
###xml 581 586 <span type="species:ncbi:9606">women</span>
###xml 747 752 <span type="species:ncbi:9606">women</span>
###xml 758 761 <span type="species:ncbi:10566">HPV</span>
European (E), Asian-American (AA) and African (Af) variants were identified. Here we show that inverse association between DQB1*05 (adjusted odds ratio [OR] = 0.66; 95% confidence interval [CI]: 0.39-1.12]) and HPV-16 positive ICC in our previous report was mostly attributable to AA variant carriers (OR = 0.27; 95%CI: 0.10-0.75). We observed similar proportions of HLA DRB1*1302 carriers in E-P positive cases and controls, but interestingly, this allele was not found in AA cases (p = 0.03, Fisher exact test). A positive association with DRB1*15 was observed in both groups of women harboring either E (OR = 2.99; 95% CI: 1.13-7.86) or AA variants (OR = 2.34; 95% CI: 1.00-5.46). There was an inverse association between DRB1*04 and ICC among women with HPV-16 carrying the 350T [83L] single nucleotide polymorphism in the E6 gene (OR = 0.27; 95% CI: 0.08-0.96). An inverse association between DQB1*05 and cases carrying 350G (83V) variants was also found (OR = 0.37; 95% CI: 0.15-0.89).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 125 128 <span type="species:ncbi:10566">HPV</span>
Our results suggest that the association between HLA polymorphism and risk of ICC might be influenced by the distribution of HPV-16 variants.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 782 783 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 87 92 <span type="species:ncbi:9606">women</span>
###xml 209 214 <span type="species:ncbi:9606">women</span>
###xml 273 278 <span type="species:ncbi:9606">women</span>
###xml 350 370 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 372 375 <span type="species:ncbi:10566">HPV</span>
###xml 515 518 <span type="species:ncbi:10566">HPV</span>
###xml 599 602 <span type="species:ncbi:10566">HPV</span>
###xml 624 627 <span type="species:ncbi:10566">HPV</span>
###xml 697 702 <span type="species:ncbi:9606">women</span>
###xml 795 798 <span type="species:ncbi:10566">HPV</span>
Invasive cervical cancer (ICC) is one of the leading causes of cancer-related death in women in developing countries. According to the WHO, the age-adjusted incidence rate of ICC in Brazil is 23.4 per 100,000 women [1], making it the second most common cancer in Brazilian women. The major risk factor is persistent infection with oncogenic types of human papillomavirus (HPV) with the contribution of additional co-factors such as smoking and oral contraceptive use. A strong association exists between persistent HPV infections and risk of squamous intraepithelial lesions (SIL), particularly for HPV types 16 and 18 [2]. HPV DNA sequences are found in 2% to 44% of sexually-active asymptomatic women [3], but virtually all cervical carcinomas contain DNA of the high-risk types [4]. However, HPV infection is necessary but not sufficient to cause the development of ICC.
###end p 11
###begin p 12
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 591 592 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 0 3 <span type="species:ncbi:10566">HPV</span>
###xml 59 64 <span type="species:ncbi:9606">women</span>
###xml 84 87 <span type="species:ncbi:10566">HPV</span>
###xml 234 239 <span type="species:ncbi:9606">human</span>
###xml 410 413 <span type="species:ncbi:10566">HPV</span>
###xml 583 586 <span type="species:ncbi:10566">HPV</span>
###xml 626 629 <span type="species:ncbi:10566">HPV</span>
###xml 680 683 <span type="species:ncbi:10566">HPV</span>
HPV-16 is the most common type found in ICC and in healthy women. Investigations of HPV-16 sequence variability worldwide suggest that the virus evolved along five major phylogenetic branches that largely reflect the ethnicity of the human host populations [5]. Studies from different populations described that non European variants, mainly from the Asian-American branch, are associated with higher risks of HPV persistence and CIN development [6], as well as ICC [7]. Different biological and biochemical properties have already been attributed to naturally occurring variants of HPV-16 [8-11], and a differential risk for HPV persistence and ICC was also associated with some HPV-16 variants [12,13].
###end p 12
###begin p 13
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 22 25 <span type="species:ncbi:10566">HPV</span>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 154 157 <span type="species:ncbi:10566">HPV</span>
###xml 387 390 <span type="species:ncbi:10566">HPV</span>
The increased rate of HPV related diseases in patients with cellular immunodeficiency suggests an important role of the immune response in the control of HPV infection [14]. Due to the crucial function of HLA class II molecules on antigen presentation to CD4 T cells, as well as the high polymorphism of HLA genes, many studies investigated associations between HLA class II alleles and HPV associated diseases [[15-17], for review see [18]].
###end p 13
###begin p 14
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*05 </italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 269 280 269 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*15</italic>
###xml 281 291 281 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 349 354 <span type="species:ncbi:9606">women</span>
###xml 458 461 <span type="species:ncbi:10566">HPV</span>
###xml 637 640 <span type="species:ncbi:10566">HPV</span>
A decreased risk of ICC was observed in carriers of DQB1*05 in our previous case-control study conducted in a Northeastern Brazilian population [19], and similar associations were found in studies conducted in the British population [20,21]. Positive associations with HLA-DRB1*15-DQB1*0602 were reported in Brazilian [19], British [20] and Swedish women [22], as well as Hispanics from New Mexico [23]. However, this haplotype was inversely associated with HPV-16 high-grade SIL (HSIL) in a study performed in United States [24]. The conflicting data concerning some of HLA associations among different populations may be influenced by HPV-16 variability, because variants can be immunologically distinct, since some sequence changes occur in potential HLA class II and I epitopes.
###end p 14
###begin p 15
###xml 162 172 162 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1501 </italic>
###xml 176 186 176 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 369 376 369 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*04</italic>
###xml 377 385 377 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*03 </italic>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DR4</italic>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQ3 </italic>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 71 74 <span type="species:ncbi:10566">HPV</span>
###xml 155 160 <span type="species:ncbi:9606">women</span>
###xml 231 234 <span type="species:ncbi:10566">HPV</span>
###xml 299 304 <span type="species:ncbi:9606">women</span>
Previous studies were conducted to investigate the association between HPV-16 variants and HLA class II polymorphism in different populations. In Japanese women, DRB1*1501 and DQB1*0602 alleles are associated with ICC positive for HPV-16 prototype [25]. A study done with Swedish, Italian and Czech women revealed a trend for a positive association between carriers of DRB1*04-DQB1*03 haplotypes and ICC positive for E6 83V variants [26]. The same amino acid substitution was associated with HLA-DRB1*07 [27] and DR4-DQ3 [28] in Dutch and Swedish populations, respectively. Conversely, no associations were found in a British study [20].
###end p 15
###begin p 16
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 245 253 245 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1</italic>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQA1 </italic>
###xml 113 116 <span type="species:ncbi:10566">HPV</span>
###xml 147 150 <span type="species:ncbi:10566">HPV</span>
###xml 173 181 <span type="species:ncbi:9606">patients</span>
To investigate if the association pattern between HLA class II genes and ICC is dependent on the distribution of HPV-16 variants, we evaluated the HPV-16 variability in 107 patients enrolled in a case-control study [19], previously analyzed for HLA-DRB1, DQB1 and DQA1 polymorphisms.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Samples
###end title 18
###begin p 19
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 8 11 <span type="species:ncbi:10566">HPV</span>
###xml 132 135 <span type="species:ncbi:10566">HPV</span>
###xml 242 247 <span type="species:ncbi:9606">women</span>
###xml 433 438 <span type="species:ncbi:9606">women</span>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
###xml 1465 1468 <span type="species:ncbi:10566">HPV</span>
###xml 1511 1514 <span type="species:ncbi:10566">HPV</span>
The 107 HPV-16 positive cases and 257 controls included in the present study were selected from an epidemiological study of ICC and HPV infection previously conducted in Brazil, whose details have been presented elsewhere [29,19]. Cases were women with histopathological confirmation of squamous ICC admitted for diagnosis and treatment at the Napoleao Laureano Hospital, in Joao Pessoa, Brazil, between 1986 and 1990. Controls were women with normal or inflammatory Pap smears selected from a citywide opportunistic screening program carried out at the same hospital. Written informed consent was obtained from all patients and controls, and ethical review committee of the Hospital Napoleao Laureano and of the Hospital do Cancer A C Camargo/Fundacao Antonio Prudente approved the study. Risk factor information was obtained through a standardized interview carried out by a trained nurse using a structured questionnaire. Ethnicity was identified by the nurse according to previously designated categories (white, mulatto and black). A cervical cell specimen was collected from each control using a cytobrush, and tumor biopsies were obtained from all cases. Clinical specimens were prepared and submitted to cytological or histological examination, and the remaining cells and tissues were stored at -20degreesC and shipped in dry ice to the Ludwig Institute for Cancer Research (Sao Paulo, Brazil) to DNA extraction. Aliquots of the purified DNA were used for HPV detection and typing, characterization of HPV-16 variants as well as for HLA typing.
###end p 19
###begin title 20
###xml 0 3 <span type="species:ncbi:10566">HPV</span>
HPV typing
###end title 20
###begin p 21
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 330 332 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 19 22 <span type="species:ncbi:10566">HPV</span>
###xml 378 381 <span type="species:ncbi:10566">HPV</span>
DNA extraction and HPV detection and typing were performed by standard techniques [29]. Briefly, DNA samples from cases and controls were submitted to PCR-based amplification of a 450 bp segment in the L1 viral gene with MY09 and MY11 primers [30]. PCR products were dot blotted in a Nylon membrane and hybridized with individual 32P-labeled oligonucleotide probes specific for HPV types 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51-59, 66, 68, 70, 71, 72, 81, 82, 83 and 89 [31,32].
###end p 21
###begin title 22
###xml 20 23 <span type="species:ncbi:10566">HPV</span>
Characterization of HPV-16 variants
###end title 22
###begin p 23
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E6 </italic>
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L1 </italic>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E6 </italic>
###xml 504 506 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 568 570 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 0 3 <span type="species:ncbi:10566">HPV</span>
HPV-16 variants were characterized for E6 and L1 genes by nested PCR, followed by hybridization with oligonucleotide probes [33]. The probes sequences and washing temperatures were as described by before [33], except the E6 350G and 403A, washed at 47degreesC. The hybridization pattern of each sample with all the probes allows the classification of variants into European (E), Asian-American (AA), African-1 (Af-1) and African-2 (Af-2) branches, and two additional subclasses within E and AA branches [34]. Variant designation was done according to previous report [35].
###end p 23
###begin p 24
###xml 211 218 211 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 372 379 368 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli </italic>
###xml 989 992 985 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E6 </italic>
###xml 996 998 992 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L1</italic>
###xml 211 218 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 372 378 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
###xml 908 911 <span type="species:ncbi:10566">HPV</span>
Some specimens were further characterized by sequencing analysis of viral gene fragments. L1 PCR products were cloned using the Sure Clone ligation kit (Amersham Pharmacia, New Jersey, USA) and transformed into E. coli, strain DH5alpha. E6 PCR products cloning were done with TOPO TA Cloning kit (Invitrogen, Carlsbad, USA) and transformed into TOP10 Chemically competent E.coli (Invitrogen, Carlsbad, USA). Clones were screened by PCR with plasmid specific primers, and these PCR products were sequenced using Big-Dye Terminator (Applied Biosystems, Foster City, USA) and one of the primers used in the PCR. Sequences were analyzed in an ABI3100 sequencer (Applied Biosystems, Foster City, USA). To identify infections by multiple variants, five clones from each transformation were selected for sequencing analysis. Samples were classified as positive for multiple infections only if clones from different HPV-16 branches were identified in one gene fragment and confirmed in the other (E6 and L1).
###end p 24
###begin title 25
HLA typing
###end title 25
###begin p 26
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 185 193 185 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQA1</italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 33 36 <span type="species:ncbi:10566">HPV</span>
All the 257 controls and the 112 HPV-16 positive cases used in this study had been previously typed for HLA class II genes [19]. Typing was done by PCR-amplification of the 2nd exon of HLA-DQA1, DQB1 and DRB1 genes, followed by hybridization with sequence-specific oligonucleotide probes [36].
###end p 26
###begin title 27
Statistical analysis
###end title 27
###begin p 28
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 101 104 <span type="species:ncbi:10566">HPV</span>
To evaluate the differences in the distribution of HLA group frequencies between cases carrying each HPV-16 variant and controls, odds ratios (OR) and respective 95% confidence intervals (95% CI) were calculated. Crude and age- and ethnicity-adjusted ORs were computed by unconditional logistic regression, using SPSS statistical software (version 11.0). In our previous study [19] other variables (level of education, income, consumption of alcoholic beverages other than beer or sugar cane distillates) were also controlled for because of their association with ethnicity. In the interest of precision, however, as similar estimates were obtained using models based on both sets of confounders we used only adjustment for age and ethnicity. All the associations that were analyzed are reported.
###end p 28
###begin title 29
Results
###end title 29
###begin p 30
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 0 3 <span type="species:ncbi:10566">HPV</span>
###xml 91 94 <span type="species:ncbi:10566">HPV</span>
###xml 281 284 <span type="species:ncbi:10566">HPV</span>
###xml 342 345 <span type="species:ncbi:10566">HPV</span>
###xml 421 424 <span type="species:ncbi:10566">HPV</span>
###xml 949 952 <span type="species:ncbi:10566">HPV</span>
###xml 1070 1073 <span type="species:ncbi:10566">HPV</span>
HPV-16 variants from E, AA, Af-1 and Af-2 branches were identified in 107 cases out of 112 HPV-16 positive ICC cases, because five samples were not included in variant analysis due to PCR failure or disagreement between variant identity in E6 and L1 genes. Although we detected 36 HPV positive samples in the control group [19], only 12 were HPV-16 positive. Due to this small number of carriers, we did not characterize HPV-16 variability in the control group. The frequency of cases harboring AA variants was similar to the frequency of cases with E variants, while a low proportion of African variants was observed, being 8 of Af-2 branch, and only one Af-1 variant (Table 1). We identified double infections by variants from different branches in 15 cases, 13 of which were carriers of AA and European prototype (E-P) variants, one positive for E-P and Af-2, and the other one carrying AA and Af-2 variants. Only one case harbored two different HPV-16 variants of the same branch, the European. The AAa variant, which belongs to the AA branch, was the most frequent HPV-16 variant in this series. From the same branch, we identified one NA-1 variant. The second most common variant was the E-P, from the E branch. We also identified an E-6994A, an E-G131T and 4 E-350G variants.
###end p 30
###begin p 31
###xml 16 19 <span type="species:ncbi:10566">HPV</span>
###xml 58 61 <span type="species:ncbi:10566">HPV</span>
Distribution of HPV-16 variants in cervical biopsies from HPV-16 positive ICC cases
###end p 31
###begin p 32
a) -: Residue identical to the E-P;
###end p 32
###begin p 33
b) Percentages are shown only for variant branches and for the most common variant groups;
###end p 33
###begin p 34
###xml 23 26 <span type="species:ncbi:10566">HPV</span>
c) The total number of HPV-16 variants exceeds 107 because we included cases with infection by more than one variant;
###end p 34
###begin p 35
d) Co-infections with other types excluded.
###end p 35
###begin p 36
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15 </italic>
###xml 103 112 103 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1503</italic>
###xml 113 123 113 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 189 199 189 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0101 </italic>
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*05 </italic>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 264 267 <span type="species:ncbi:10566">HPV</span>
In our previous case-control study performed with these samples, we have reported that DRB1*15 and the DRB1*1503-DQB1*0602 haplotype were positively associated with ICC. On the other hand, DRB1*0101 and DQB1*05 were inversely associated with this disease [19]. As HPV-16 was the most common type found in those samples, we extended the type-specific analysis and the most relevant results are shown in Table 2.
###end p 36
###begin p 37
###xml 20 23 <span type="species:ncbi:10566">HPV</span>
ORs and 95% CIs for HPV-16 positive ICC according to HLA.
###end p 37
###begin p 38
a) C/N: Carriers/Non carriers;
###end p 38
###begin p 39
b) OR: Odds Ratio;
###end p 39
###begin p 40
c) CI: Confidence Interval;
###end p 40
###begin p 41
d) Adjusted for age and ethnic group.
###end p 41
###begin p 42
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 86 89 <span type="species:ncbi:10566">HPV</span>
###xml 174 177 <span type="species:ncbi:10566">HPV</span>
###xml 347 350 <span type="species:ncbi:10566">HPV</span>
###xml 413 416 <span type="species:ncbi:10566">HPV</span>
To perform the analysis of HLA distribution we first excluded 33 cases that contained HPV types other than 16, and then excluded 5 cases that were positive for more than one HPV-16 variant, as the influence of one variant in immune response to another is not clear. We therefore evaluated the HLA distribution in 69 cases, which were positive for HPV-16 only and had a single variant infection, and 257 controls. HPV-16 variants distribution in these cases is also shown in Table 1.
###end p 42
###begin p 43
###xml 18 26 18 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQA1</italic>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1 </italic>
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 235 252 235 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQA1*0101/04 </italic>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 413 421 413 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*05 </italic>
###xml 425 433 425 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*01 </italic>
###xml 486 498 486 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQB1*05 </italic>
###xml 502 512 502 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0501 </italic>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 598 608 598 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1302 </italic>
###xml 794 795 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
The comparison of HLA-DQA1, DQB1 and DRB1 alleles' distribution between controls and cases, which were stratified according to major variants E-P and AA found in this sample, is presented on Table 3. We observed that the proportion of HLA-DQA1*0101/04 carriers was lower in cases positive for AA variants than in controls (Table 3). Due to linkage disequilibrium, this allele is commonly found in haplotypes with DQB1*05 and DRB1*01 alleles. As expected, an inverse association between HLA-DQB1*05 and DQB1*0501 carriers was also observed with AA variant cases (Table 3). Interestingly, the allele DRB1*1302 was not found among AA positive cases (p = 0.03, Fisher exact test), although its frequency was not statistically different between controls and ICC cases positive for E variants (Table 3).
###end p 43
###begin p 44
###xml 24 27 <span type="species:ncbi:10566">HPV</span>
ORs and 95% CIs for ICC HPV-16EP or AA positive according to HLA.
###end p 44
###begin p 45
###xml 22 36 22 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQA1*0102 </italic>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 225 235 225 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQA1*0102 </italic>
###xml 268 278 268 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1-DQB1 </italic>
###xml 314 322 314 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15 </italic>
###xml 326 336 326 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 366 374 366 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15 </italic>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 560 570 560 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1503 </italic>
###xml 712 720 712 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15 </italic>
###xml 769 778 769 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602</italic>
###xml 867 874 867 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15</italic>
###xml 924 934 924 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 960 968 960 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*11 </italic>
A higher frequency of HLA-DQA1*0102 was found in cases positive for E variants (adjusted OR = 2.32, 95% CI: 0.96-5.62; Table 3; p = 0.06) than in controls, but not in those associated with AA variants (Table 3). Although the DQA1*0102 allele can be found in different DRB1-DQB1 haplotypes, we found it mainly with DRB1*15 and DQB1*0602 alleles. The association with DRB1*15 was comparable between European variants (OR = 2.99; 95% CI: 1.13-7.86; p = 0.03) and AA variants (OR = 2.34; 95% CI: 1.00-5.46, p = 0.05) (Table 3). In both European and AA groups, the DRB1*1503 allele had the highest OR values (adjusted OR = 3.75; 95% CI: 0.99-12.42; p = 0.05 and OR = 2.62; 95% CI: 0.83-8.27; p = 0.10, respectively). DRB1*15 alleles are found in linkage disequilibrium with DQB1*0602. However, it is worth noting that this allele was found, in most cases, in linkage with DRB1*15, whereas in the controls, a larger proportion of DQB1*0602 was found in linkage with DRB1*11 alleles.
###end p 45
###begin p 46
###xml 63 77 63 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1-DQB1 </italic>
###xml 142 149 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15</italic>
###xml 150 160 150 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 299 308 299 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0102</italic>
###xml 309 319 309 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0501 </italic>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
The only statistically significant result in the comparison of HLA-DRB1-DQB1 haplotypes in the stratified analysis was an association between DRB1*15-DQB1*0602 and E-variant cases (p = 0.02, Table 3). Similar to the trends observed for the distribution of alleles, we found a lower frequency of the DRB1*0102-DQB1*0501 haplotype in patients carrying AA variants (adjusted OR = 0.18; 95% CI: 0.02-1.44; Table 3; p = 0.11) than in E carriers (adjusted OR = 2.18; CI: 0.75-6.29; Table 3, p = 0.15).
###end p 46
###begin p 47
###xml 151 167 151 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*07-DQB1*02 </italic>
Although the number of African variants was too small to allow any stratified analysis, it is of relevance that 4 of the 8 Af-2 cases were carriers of DRB1*07-DQB1*02 haplotype (in the control group, this haplotype was identified in 47 of the 257 controls).
###end p 47
###begin p 48
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E6 </italic>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 414 422 414 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*05 </italic>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 505 513 505 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*05 </italic>
###xml 614 624 614 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0501 </italic>
###xml 677 685 677 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*04 </italic>
###xml 774 775 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 815 823 <span type="species:ncbi:9606">patients</span>
To verify if T to G substitution at 350 nucleotide position in the E6 viral oncogene could interfere in HLA association with ICC, we stratified cases according to this polymorphism and results of this analysis are on Table 4. The E6 83V group was composed of cases harbouring AA and the E-350G variants, while other E variants and Af variants formed the 83L group. Despite the observed inverse association between DQB1*05 and 83V cases (OR = 0.37; 95% CI: 0.15-0.89; Table 4, p = 0.03), the proportion of DQB1*05 carriers in 83L cases was not different from controls. Similar tendencies were also verified for the DQB1*0501 allele. We also found an inverse association between DRB1*04 and ICC cases positive for 83L E6 variants (adjusted OR = 0.27; 95% CI: 0.08-0.96; Table 4, p = 0.04), which was not observed for patients carrying 83V E6 variants.
###end p 48
###begin p 49
###xml 20 23 <span type="species:ncbi:10566">HPV</span>
ORs and 95% CIs for HPV-16/E6-83V or E6-83L positive ICC according to HLA
###end p 49
###begin p 50
###xml 17 27 17 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQA1*0102 </italic>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 185 193 185 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15 </italic>
###xml 215 224 215 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1503</italic>
###xml 419 426 419 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15</italic>
###xml 427 437 427 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 441 450 441 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1503</italic>
###xml 451 461 451 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 565 566 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 712 722 712 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*09012</italic>
###xml 723 736 723 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0201/02 </italic>
###xml 829 830 829 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
The frequency of DQA1*0102 carriers was higher in cases carrying 83L E6 variants (OR = 2.24; 95% CI: 0.99-5.09, p = 0.05) than in controls (Table 4). Increased risks were also seen for DRB1*15 alleles, particularly DRB1*1503. However, statistical significance was only unequivocal for cases with 83L variants (OR = 3.87, 95% CI: 1.20-12.52, p = 0.02). The analysis of haplotypes revealed a positive association between DRB1*15-DQB1*0602 and DRB1*1503-DQB1*0602 (OR = 2.86; 95% CI: 1.14-7.16, p = 0.02 and OR = 3.87; 95% CI: 1.20-12.52, p = 0.02 respectively; Table 4) with 83L carriers. Similar trends were found for 83V variants but they did not reach statistical significance. Despite the low frequency of the DRB1*09012-DQB1*0201/02 haplotype in this sample, it was positively associated with ICC carrying 83L variants (Table 4).
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 69 84 69 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DQA1, DQB1 </italic>
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1 </italic>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1071 1072 1071 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1184 1185 1184 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1336 1338 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1671 1673 1671 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1674 1676 1674 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1860 1861 1860 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1862 1864 1862 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 49 52 <span type="species:ncbi:10566">HPV</span>
###xml 147 152 <span type="species:ncbi:9606">women</span>
###xml 214 217 <span type="species:ncbi:10566">HPV</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
###xml 958 963 <span type="species:ncbi:9606">women</span>
###xml 1034 1037 <span type="species:ncbi:10566">HPV</span>
###xml 1149 1154 <span type="species:ncbi:9606">women</span>
###xml 1328 1331 <span type="species:ncbi:10566">HPV</span>
###xml 1369 1372 <span type="species:ncbi:10566">HPV</span>
###xml 1568 1571 <span type="species:ncbi:10566">HPV</span>
In this report we analyzed the interplay between HPV-16 variants and HLA-DQA1, DQB1 and DRB1 variability on the susceptibility to ICC in Brazilian women. We found similar frequencies of European (prototype) and AA HPV-16 variants in our group of cases and a lower proportion of African variants in samples from cervical cancer patients. In agreement with a previous study by our team of a different Brazilian population [6], the major European variant found in these samples was the prototype. Non-European variants are associated with greater risk of cervical lesions than European ones but results have not been uniform across populations. Some studies were conducted in European populations [20,27,37] and conflicting results were observed, probably due to the predominance of lower risk European variants in those populations [38]. The relatively high proportion of AA variants in our cases agrees with our previous observation in asymptomatic Brazilian women that indicate that these variants are associated with higher risks of HPV persistence and CIN development [6]. A case-control study done in Mexico also revealed a higher ICC risk among women carrying AA than E variants [7]. Data obtained from such admixtured populations in the Americas show a reproducible pattern of risk associated with non-European variants of HPV-16 [38]. The diverse distribution of HPV variants between cases and controls from several populations can reflect differences in their oncogenic potential. It has been suggested that differences in the LCR sequence might play a role in HPV-induced tumorigenesis, because nucleotide changes can alter promoter activity of the viral genome [39,40]. On the other hand, variations in coding regions, such as in E6 gene sequences could also explain this diverse oncogenic potential of variants through differential protein activity [8-11].
###end p 52
###begin p 53
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*15</italic>
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*06 </italic>
###xml 180 192 180 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1*13 </italic>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 403 412 403 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0407</italic>
###xml 413 423 413 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0302 </italic>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 566 576 566 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1503 </italic>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 788 794 788 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DR*15 </italic>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 75 78 <span type="species:ncbi:10566">HPV</span>
###xml 375 378 <span type="species:ncbi:10566">HPV</span>
###xml 464 467 <span type="species:ncbi:10566">HPV</span>
###xml 498 503 <span type="species:ncbi:9606">women</span>
###xml 581 584 <span type="species:ncbi:10566">HPV</span>
###xml 631 634 <span type="species:ncbi:10566">HPV</span>
###xml 724 729 <span type="species:ncbi:9606">women</span>
###xml 869 872 <span type="species:ncbi:10566">HPV</span>
###xml 975 978 <span type="species:ncbi:10566">HPV</span>
Several studies investigated the role of HLA class II genes and alleles in HPV related diseases. Positive associations with DRB1*15-DQB1*06 haplotype and inverse associations with HLA-DRB1*13 allele were described in different populations, including Brazilians [19], Americans/Hispanics [23] and Europeans [20,22]. In some of these studies, associations with cases harboring HPV-16 have been suggested: DRB1*0407-DQB1*0302 haplotype was positively associated with HPV-16 positive cases in Hispanic women [23]. Likewise, we have previously reported an association of DRB1*1503 with HPV positive ICC, with higher OR values when only HPV-16 cases were considered [19], but in this report we found similar results when compared women harboring E and AA variants. Since associations involving DR*15 alleles were observed in many populations [20,22,23,41-43], with different HPV variants, it is reasonable to speculate an effect of this allele on cervical disease independently of HPV-16 variants distribution.
###end p 53
###begin p 54
###xml 153 166 153 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQA1*0101/04 </italic>
###xml 170 178 170 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*05 </italic>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 323 330 323 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*05</italic>
###xml 470 473 470 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E6 </italic>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 56 59 <span type="species:ncbi:10566">HPV</span>
###xml 135 138 <span type="species:ncbi:10566">HPV</span>
###xml 631 634 <span type="species:ncbi:10566">HPV</span>
On the other hand, stratification of cases according to HPV-16 variants allowed us to find that trends of inverse associations between HPV-16 cases with DQA1*0101/04 and DQB1*05 [19] are due to AA variants. Previous studies involving populations with few AA variants [26-28] did not report the association of AA cases with DQB1*05. Due to the high prevalence of E variants in these studies, they took into consideration mostly single nucleotide polymorphisms, as in the E6 gene, which generates variants designated L83V (T to G substitution at 350 nucleotide position). This substitution was associated with and increased risk for HPV persistence and ICC [12].
###end p 54
###begin p 55
###xml 45 53 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*13 </italic>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 305 315 305 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1302 </italic>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 375 385 375 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1302 </italic>
###xml 102 107 <span type="species:ncbi:9606">women</span>
###xml 246 251 <span type="species:ncbi:9606">women</span>
Inverse associations of cervical cancer with DRB1*13 group were found in Costa Rica [44] and Hispanic women from USA [23]; as well as Swedish [22]; French [45] and Dutch [42] populations. A trend for negative association was observed in American women [24], similar to what we observed previously between DRB1*1302 and ICC cases [19]. In our present study, the comparison of DRB1*1302 frequency between controls and European variants cases did not reveals any association, but, interestingly, this allele was not found in ICC cases positive for AA variants, suggesting a protective role of this allele to cases carrying AA variants.
###end p 55
###begin p 56
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*04</italic>
###xml 129 139 129 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0302 </italic>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DR*04</italic>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQ*03 </italic>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 576 585 576 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*0401</italic>
###xml 586 596 586 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0301 </italic>
###xml 600 609 600 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1101</italic>
###xml 610 620 610 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0301 </italic>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 31 36 <span type="species:ncbi:9606">women</span>
###xml 469 472 <span type="species:ncbi:10566">HPV</span>
We found a lower proportion of women carrying DR4 in 83L cases than in controls, and a similar trend was observed in the DRB1*04-DQB1*0302 haplotype comparison (data not shown). Interestingly, in a Swedish population, the frequency of DR*04-DQ*03 haplotype was higher in cases with 83V variant than in controls [28]; and similar trends were also described for Italian, Czech and other Swedish populations [26]. A study conducted in the British population revealed that HPV-16 E2 variants, which also present the E6 350G (83V), occurred more frequently in individuals with HLA-DRB1*0401-DQB1*0301 and DRB1*1101-DQB1*0301 haplotypes [46].
###end p 56
###begin p 57
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DR4 </italic>
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQ3 </italic>
###xml 567 576 567 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0302</italic>
###xml 654 664 654 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0301 </italic>
###xml 668 674 668 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">*0303 </italic>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 17 20 <span type="species:ncbi:10566">HPV</span>
###xml 841 873 <span type="species:ncbi:10623">cottontail rabbit papillomavirus</span>
###xml 953 960 <span type="species:ncbi:9986">rabbits</span>
The influence of HPV-16 variants in HLA distribution in ICC cases suggests that variants can differ in their immunogenic potential. Although there are few studies and most of them restricted to small sample sizes, which limits the interpretation of some findings, it is possible that the associations can reflect alterations in the binding of viral epitopes to HLA molecules. The DR4 alleles found here are in linkage disequilibrium with DQ3 and it was already detected that a substitution of a residue in a HSV peptide impaired its binding to DQ3.2 molecule (allele DQB1*0302), but this altered peptide become able to bind to DQ3.1 and DQ3.3 molecules (DQB1*0301 and *0303 alleles, respectively) [47]. Functional consequences of alterations in viral proteins were demonstrated in animal models, and a single residue change in E6 protein of cottontail rabbit papillomavirus progressor strain led to high frequencies of spontaneous regressions in inbred rabbits [48]. Variations in E6 protein from AA and E variants differ in peptide positions (14H, 83V) that are encompassed by the epitopes described earlier [49,50], but further evaluation is warranted to elucidate a possible role of these substitutions in immune response.
###end p 57
###begin p 58
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 786 795 786 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1501</italic>
###xml 796 806 796 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0602 </italic>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 910 920 910 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DRB1*1301 </italic>
###xml 924 933 924 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DQB1*0603</italic>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 74 77 <span type="species:ncbi:10566">HPV</span>
###xml 124 127 <span type="species:ncbi:10566">HPV</span>
###xml 248 251 <span type="species:ncbi:10566">HPV</span>
###xml 574 577 <span type="species:ncbi:10566">HPV</span>
###xml 828 831 <span type="species:ncbi:10566">HPV</span>
###xml 946 949 <span type="species:ncbi:10566">HPV</span>
###xml 1047 1050 <span type="species:ncbi:10566">HPV</span>
###xml 1238 1241 <span type="species:ncbi:10566">HPV</span>
In our previous report, we did not detect many differences when comparing HPV negative and positive controls [19]. However, HPV detection was performed in a single point in time. In our longitudinal study, different haplotypes were associated with HPV infections and/or persistence [51], but this study was conducted in a population of a different region in Brazil, which could reflect differences in HLA distribution. Bontkes et al. 1998 [27] suggest that immunogenetic factors associated with disease progression are different from those associated with susceptibility to HPV-16 infection. However, Beskow et al., 2002 [52] found a strong correlation between long-term infection and high viral load and between short-term infection and low viral load. They described that carriers of DRB1*1501-DQB1*0602 haplotype, had higher HPV-16 viral load than non-carriers [52] and that carriers of protective alleles (DRB1*1301 and DQB1*0603) have lower HPV-18/45 load compared to non carriers [53]. These results suggest an interaction between viral (as HPV types, variants and viral load) and host factors, and it is possible that HLA polymorphism may affect the immune reaction to the virus and indirectly play a role in the susceptibility to HPV-related lesions.
###end p 58
###begin title 59
Conclusion
###end title 59
###begin p 60
###xml 37 40 <span type="species:ncbi:10566">HPV</span>
###xml 180 183 <span type="species:ncbi:10566">HPV</span>
###xml 235 238 <span type="species:ncbi:10566">HPV</span>
Taken together our data suggest that HPV-16 variability influences the association between HLA polymorphism and ICC risk. Studies to elucidate its influence in immune responses to HPV, and its role in viral clearance or progression of HPV-related diseases are warranted.
###end p 60
###begin title 61
Abbreviations
###end title 61
###begin p 62
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 56 59 <span type="species:ncbi:10566">HPV</span>
###xml 61 81 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 189 192 <span type="species:ncbi:10566">HPV</span>
###xml 228 231 <span type="species:ncbi:10566">HPV</span>
###xml 264 267 <span type="species:ncbi:10566">HPV</span>
CI: confidence intervals; HLA: human leukocyte antigen; HPV: human papillomavirus; OR: odds ratio; ICC: invasive cervical carcinoma; PCR: polymerase chain reaction; E: European variants of HPV-16; AA: Asian-American variants of HPV-16; Af-2: African-2 variants of HPV-16.
###end p 62
###begin title 63
Competing interests
###end title 63
###begin p 64
The authors declare that they have no competing interests.
###end p 64
###begin title 65
Authors' contributions
###end title 65
###begin p 66
###xml 21 24 <span type="species:ncbi:10566">HPV</span>
PSAS carried out the HPV-16 variants typing, participated HLA typing and drafted the manuscript. PCM carried out the HLA typing and participated in study design. KBR performed the statistical analysis. MLP-E coordinated the HLA typing and participated in study design. ELF and LLV participated in the study design and supervised the study. All authors read and approved the final manuscript.
###end p 66
###begin title 67
Pre-publication history
###end title 67
###begin p 68
The pre-publication history for this paper can be accessed here:
###end p 68
###begin p 69

###end p 69
###begin title 70
Acknowledgements
###end title 70
###begin p 71
###xml 212 217 <span type="species:ncbi:9606">women</span>
###xml 280 283 <span type="species:ncbi:10566">HPV</span>
We thank Drs J Simoes, M Farias, C Seixas, L Araujo, I Arruda, P Honorato and F Honorato (Hospital Napoleao Laureano, Joao Pessoa, Brazil) for subject accrual and A Silva for specimens collection of asymptomatic women and conducting the interviews; MC Costa e AV Novello Neto for HPV typing; AC Salim and E Monteiro for sequencing.
###end p 71
###begin p 72
This work was supported by the CNPq, FAPESP and the Ludwig Institute for Cancer Research.
###end p 72
###begin article-title 73
GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide
###end article-title 73
###begin article-title 74
###xml 11 31 <span type="species:ncbi:10566">human papillomavirus</span>
Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia
###end article-title 74
###begin article-title 75
###xml 28 48 <span type="species:ncbi:10566">human papillomavirus</span>
The epidemiology of genital human papillomavirus infection
###end article-title 75
###begin article-title 76
###xml 0 20 <span type="species:ncbi:10566">Human papillomavirus</span>
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
###end article-title 76
###begin article-title 77
###xml 21 49 <span type="species:ncbi:333760">human papillomavirus type 16</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations
###end article-title 77
###begin article-title 78
###xml 22 42 <span type="species:ncbi:10566">human papillomavirus</span>
Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia
###end article-title 78
###begin article-title 79
###xml 27 50 <span type="species:ncbi:333760">human papillomavirus 16</span>
Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study
###end article-title 79
###begin article-title 80
###xml 24 52 <span type="species:ncbi:333760">human papillomavirus type 16</span>
Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation
###end article-title 80
###begin article-title 81
###xml 0 28 <span type="species:ncbi:333760">Human papillomavirus type 16</span>
Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras
###end article-title 81
###begin article-title 82
###xml 14 37 <span type="species:ncbi:333760">human papillomavirus 16</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
Activities of human papillomavirus 16 E6 natural variants in human keratinocytes
###end article-title 82
###begin article-title 83
HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6
###end article-title 83
###begin article-title 84
###xml 0 20 <span type="species:ncbi:10566">Human papillomavirus</span>
###xml 101 106 <span type="species:ncbi:9606">women</span>
Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities
###end article-title 84
###begin article-title 85
###xml 0 23 <span type="species:ncbi:333760">Human papillomavirus 16</span>
Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype
###end article-title 85
###begin article-title 86
###xml 20 40 <span type="species:ncbi:10566">human papillomavirus</span>
Immune responses to human papillomavirus
###end article-title 86
###begin article-title 87
###xml 55 60 <span type="species:ncbi:9606">women</span>
High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3
###end article-title 87
###begin article-title 88
HLA-DQB1*03 and cervical intraepithelial neoplasia type III
###end article-title 88
###begin article-title 89
###xml 14 19 <span type="species:ncbi:9606">human</span>
Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma
###end article-title 89
###begin article-title 90
###xml 41 61 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 100 105 <span type="species:ncbi:9606">women</span>
Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil
###end article-title 90
###begin article-title 91
###xml 88 108 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 132 137 <span type="species:ncbi:9606">women</span>
Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women
###end article-title 91
###begin article-title 92
###xml 30 33 <span type="species:ncbi:10566">HPV</span>
###xml 100 105 <span type="species:ncbi:9606">women</span>
Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women
###end article-title 92
###begin article-title 93
###xml 18 38 <span type="species:ncbi:10566">human papillomavirus</span>
Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles
###end article-title 93
###begin article-title 94
###xml 92 112 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 159 164 <span type="species:ncbi:9606">women</span>
Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women
###end article-title 94
###begin article-title 95
HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity
###end article-title 95
###begin article-title 96
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 62 82 <span type="species:ncbi:10566">human papillomavirus</span>
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States
###end article-title 96
###begin article-title 97
###xml 0 28 <span type="species:ncbi:333760">Human papillomavirus type 16</span>
###xml 81 86 <span type="species:ncbi:9606">women</span>
Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer
###end article-title 97
###begin article-title 98
###xml 0 23 <span type="species:ncbi:333760">Human papillomavirus 16</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes
###end article-title 98
###begin article-title 99
###xml 0 3 <span type="species:ncbi:10566">HPV</span>
###xml 106 109 <span type="species:ncbi:10566">HPV</span>
HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants
###end article-title 99
###begin article-title 100
Interaction of host and viral risk factors for development of cervical carcinoma in situ
###end article-title 100
###begin article-title 101
###xml 25 45 <span type="species:ncbi:10566">human papillomavirus</span>
Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic types
###end article-title 101
###begin article-title 102
###xml 32 37 <span type="species:ncbi:9606">human</span>
Detection and typing of genital human papillomaviruses
###end article-title 102
###begin article-title 103
###xml 8 28 <span type="species:ncbi:10566">human papillomavirus</span>
Genital human papillomavirus infection in female university students as determined by a PCR-based method
###end article-title 103
###begin article-title 104
###xml 24 44 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 69 74 <span type="species:ncbi:9606">women</span>
Determinants of genital human papillomavirus infection in low-income women in Washington, D.C
###end article-title 104
###begin article-title 105
###xml 0 28 <span type="species:ncbi:333760">Human papillomavirus type 16</span>
Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization
###end article-title 105
###begin article-title 106
###xml 0 28 <span type="species:ncbi:333760">Human papillomavirus type 16</span>
Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments
###end article-title 106
###begin article-title 107
###xml 0 28 <span type="species:ncbi:333760">Human papillomavirus type 16</span>
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective
###end article-title 107
###begin article-title 108
Primers and oligonucleotide probes (SSOP) used for DNA typing of HLA class II alleles
###end article-title 108
###begin article-title 109
###xml 55 78 <span type="species:ncbi:333760">human papillomavirus 16</span>
Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms
###end article-title 109
###begin article-title 110
Host and viral genetics and risk of cervical cancer: a review
###end article-title 110
###begin article-title 111
###xml 48 76 <span type="species:ncbi:333760">human papillomavirus type 16</span>
Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity
###end article-title 111
###begin article-title 112
###xml 61 89 <span type="species:ncbi:333761">human papillomavirus type 18</span>
Different P105 promoter activities among natural variants of human papillomavirus type 18
###end article-title 112
###begin article-title 113
###xml 14 19 <span type="species:ncbi:9606">human</span>
Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma
###end article-title 113
###begin article-title 114
HLA and susceptibility to cervical neoplasia
###end article-title 114
###begin article-title 115
HLA class II alleles associated with infection by HPV16 in cervical cancer in situ
###end article-title 115
###begin article-title 116
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica
###end article-title 116
###begin article-title 117
###xml 63 66 <span type="species:ncbi:10566">HPV</span>
Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix
###end article-title 117
###begin article-title 118
###xml 38 58 <span type="species:ncbi:10566">human papillomavirus</span>
Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type
###end article-title 118
###begin article-title 119
Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase
###end article-title 119
###begin article-title 120
###xml 54 86 <span type="species:ncbi:10623">cottontail rabbit papillomavirus</span>
Amino acid residues in the carboxy-terminal region of cottontail rabbit papillomavirus E6 influence spontaneous regression of cutaneous papillomas
###end article-title 120
###begin article-title 121
###xml 33 53 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 55 58 <span type="species:ncbi:10566">HPV</span>
###xml 99 102 <span type="species:ncbi:10566">HPV</span>
Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia
###end article-title 121
###begin article-title 122
###xml 20 48 <span type="species:ncbi:333760">human papillomavirus type 16</span>
Frequent display of human papillomavirus type 16 E6-specific memory T-helper cells in the healthy population as witness of previous viral encounter
###end article-title 122
###begin article-title 123
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 92 112 <span type="species:ncbi:10566">human papillomavirus</span>
Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection
###end article-title 123
###begin article-title 124
###xml 24 27 <span type="species:ncbi:10566">HPV</span>
Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri
###end article-title 124
###begin article-title 125
###xml 31 34 <span type="species:ncbi:10566">HPV</span>
HLA class II allele control of HPV load in carcinoma in situ of the cervix uteri
###end article-title 125

